What Are Normal Hormone Levels? Ranges And What They Mean

Normal hormone levels refer to the reference ranges printed on a lab report, built from population data and designed to flag values that fall outside statistical norms. For testosterone in adult men, the harmonized reference range is 264-916 ng/dL based on CDC-calibrated assay data across four large cohorts (Travison et al., 2017). For estradiol in premenopausal women, ranges typically span 30-400 pg/mL depending on the menstrual cycle phase. These numbers tell a provider whether a result sits inside or outside the expected window for a given population, but they don't tell the full story of how a client feels or functions. That's why direct-pay lab testing that pairs hormones with related biomarkers gives providers the context they need to interpret where a value falls within the range, not just whether it cleared the threshold.

Normal hormone levels are the reference ranges a laboratory assigns to a given blood test, representing the statistical window where roughly 95% of a healthy reference population's results fall. Reference ranges listed in this article are approximate and vary by laboratory. Individual results should be interpreted by a qualified provider in the setting of a complete clinical evaluation. The range doesn't distinguish between a client who is asymptomatic and one who is experiencing fatigue, low libido, or disrupted sleep. A result can sit inside the "normal" window and still coincide with symptoms that warrant clinical investigation.

How Are Normal Hormone Levels Defined?

Reference ranges are derived from large population samples. Labs measure a specific hormone in a group of healthy individuals, then define "normal" as the central 95% of results (the 2.5th to 97.5th percentile).

A few things affect how useful that window is. The population sample varies by lab. The assay method matters, and not all labs use standardized assays calibrated to a common reference (like the CDC Hormone Standardization Program). The same blood sample can be classified as low at one lab and normal at another (Travison et al., 2017). Age, sex, time of day, fasting status, and body composition all shift results within the range.

That's why clinical guidelines from the Endocrine Society and AUA don't rely on a single lab value. For testosterone deficiency specifically, they require symptoms plus consistently low results on at least two separate morning draws before a diagnosis is made (Bhasin et al., 2018).

What Are Normal Testosterone Levels?

The most widely cited harmonized data for total testosterone in men comes from Travison et al. (2017), which pooled results from the Framingham Heart Study, the European Male Ageing Study (EMAS), the Osteoporotic Fractures in Men Study, and the Male Sibling Study of Osteoporosis. In healthy, non-obese men aged 19-39, the 2.5th to 97.5th percentile range was 264-916 ng/dL, with a median of 531 ng/dL.

The AUA uses a threshold near 300 ng/dL (plus signs and symptoms) as a reasonable cut-off to support a diagnosis of testosterone deficiency (Mulhall et al., 2018). The Endocrine Society's guideline aligns with this threshold but stresses that diagnosis requires two separate early-morning fasting draws using an accurate assay, separated by 1-3 weeks, plus consistent symptoms (Bhasin et al., 2018).

For women, normal testosterone levels are much lower. Most laboratories report a reference range of approximately 15-70 ng/dL for total testosterone and 0.7-3.6 pg/mL for free testosterone, though ranges vary by lab and assay. Elevated testosterone in women can have several causes, including PCOS, and interpretation depends on the full clinical picture.

Testosterone is a Schedule III controlled substance, and any prescription requires evaluation by a licensed clinician with laboratory confirmation of deficiency and a legitimate medical indication. The FDA's current labeling specifies that testosterone products are approved only for men with low levels due to an associated medical condition (FDA, 2025). Testosterone therapy for women is not FDA-approved and, where prescribed, is considered off-label use based on individual clinical judgment.

What Are Normal Estrogen and Progesterone Levels?

Estrogen levels in women change across the menstrual cycle, pregnancy, and menopause. The primary circulating estrogen before menopause is estradiol (E2). Commonly reported laboratory ranges include:

• Premenopausal (varies by cycle phase): approximately 30-400 pg/mL

• Day 3 (early follicular, baseline fertility marker): approximately 25-75 pg/mL

• Postmenopausal: approximately 0-30 pg/mL

These values vary by lab and assay, so the specific reference range on the report is the one to use.

Progesterone follows a different pattern. Levels stay below 1.5 ng/mL in the follicular phase (before ovulation). After ovulation, progesterone rises; a mid-luteal level above 10 ng/mL is often used as one marker suggesting ovulation, though clinical correlation is needed.

Because these values shift with cycle timing, a single draw without context is hard to interpret. Providers who order hormone testing panels typically specify the cycle day to match the result to the right reference window.

What Are Normal Thyroid Hormone Levels?

Thyroid hormones affect metabolism, energy, mood, and body temperature. Most laboratories report ranges in the following vicinity, though exact values differ by lab and assay:

• TSH (thyroid-stimulating hormone): approximately 0.4-4.0 uIU/mL, with a midpoint around 1.7

• Free T4 (thyroxine): approximately 0.8-2.0 ng/dL

• Free T3 (triiodothyronine): approximately 1.4-4.4 pg/mL

A high TSH with low or normal T4 generally points toward hypothyroidism. A low TSH with elevated T3 or T4 suggests hyperthyroidism. TSH alone doesn't give the full picture. When symptoms persist despite a "normal" TSH, a provider may order additional biomarkers like free T3, thyroid antibodies, and reverse T3 to identify patterns that a basic screen misses.

What Do FSH and LH Levels Indicate?

Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are pituitary hormones that regulate reproductive function. Normal FSH values depend on age, sex, and reproductive status. Commonly reported laboratory ranges include:

• Adult men: approximately 1.5-12.4 mIU/mL

• Premenopausal women: approximately 4.7-21.5 mIU/mL (varies by cycle phase)

• Postmenopausal women: approximately 25.8-134.8 mIU/mL

In men, elevated FSH with low testosterone suggests primary hypogonadism (a problem originating in the testes). Low FSH with low testosterone points toward a pituitary or hypothalamic cause. These patterns are starting points for evaluation, not standalone diagnoses, since medications, chronic illness, and body composition can all influence these values. In women, a Day 3 FSH above 10 mIU/mL may suggest diminished ovarian reserve. An elevated LH:FSH ratio is sometimes observed in PCOS, though it isn't part of the current diagnostic criteria.

These markers are part of the broader hormone picture. Interpreting FSH and LH in isolation, without testosterone, estradiol, and clinical symptoms, risks misattribution.

Why Do Reference Ranges Vary Between Labs?

Labs use different assay methods, calibration standards, and reference populations. The CDC Hormone Standardization Program exists to reduce this variability, but adoption isn't universal. Travison et al. (2017) documented the problem directly: harmonized ranges produced consistent results across cohorts only when all labs used CDC-calibrated methods.

Without standardization, a total testosterone of 290 ng/dL could read as "low" at one lab and "normal" at another depending on the assay and reference population used. This is one reason guidelines stress repeating the test, ideally at the same lab and with the same assay, before making clinical decisions.

Can "Normal" Levels Coincide with Symptoms?

Yes. A lab result inside the reference range doesn't rule out hormone-related symptoms. The reference range covers the middle 95% of a population, which includes people who feel well and people who don't.

A client near the lower end of the reference range who reports symptoms may benefit from further evaluation, though symptoms like fatigue, reduced libido, and difficulty concentrating are non-specific and warrant broad clinical assessment before attributing them to a single lab value. Similarly, some clients with values in the upper portion of the TSH range report symptoms, though whether those symptoms are thyroid-related requires careful clinical evaluation. The clinical question isn't just whether the number is "in range." It's whether the number, combined with the client's full history, physical exam, and other labs, points toward a hormonal contribution. Whether further evaluation or treatment is appropriate depends on the full clinical picture and client goals.

This is where expanded testing adds value. A single marker tested in isolation gives less information than a panel that includes related biomarkers, binding proteins like SHBG, and supporting labs like hematocrit and estradiol.

How Should Clients Prepare for Hormone Testing?

Timing and preparation affect accuracy. For testosterone, clinical guidelines specify two early-morning fasting draws (ideally between 8:00 and 10:00 AM) because testosterone levels peak in the morning and decline through the day. A late-afternoon draw can produce a meaningfully lower result than a morning sample in the same client, which is why guidelines specify morning testing.

General preparation for blood work includes fasting for 8-12 hours when metabolic markers are part of the panel, avoiding intense exercise the day before, and staying hydrated. For women, providers should specify cycle day when ordering estradiol, progesterone, FSH, or LH, since each has a different expected range depending on cycle phase.

Clients should ask for their actual values, not just whether results are "in range." Knowing a testosterone level is 320 ng/dL versus 680 ng/dL matters clinically, even though both fall inside the standard reference range.

What Questions Should You Ask About Your Normal Hormone Levels?

Requesting specific numbers, not just pass/fail flags, gives clients a better foundation for conversations with their providers. Questions worth raising:

• What are my actual lab values, and where do they fall within the reference range?

• What assay method did the lab use, and is it CDC-calibrated?

• Are my symptoms consistent with the pattern these numbers suggest?

• Should any markers be retested at a specific time or cycle day?

• Are there related biomarkers (SHBG, hematocrit, estradiol) that would round out the picture?

Understanding normal hormone levels starts with knowing the actual numbers, where they sit in the range, and what they mean for a specific client. Marek Diagnostics gives clients access to their full lab data and connects them with providers who evaluate results against clinical evidence, not just a population average.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

How is a normal hormone level determined? 

A normal hormone level is defined by measuring a specific hormone in a large sample of healthy people and calculating the range that captures the central 95% of results. This range varies by lab, assay method, and reference population. The same blood sample can produce different classifications at different laboratories depending on calibration standards and the population used to set the range.

What total testosterone level is considered low? 

The AUA identifies total testosterone below 300 ng/dL as a reasonable diagnostic cut-off when accompanied by symptoms. The Endocrine Society requires two separate early-morning fasting draws showing consistently low levels, using an accurate assay, before recommending treatment (Bhasin et al., 2018). A single borderline result doesn't meet the threshold for diagnosis.

What are normal estrogen levels in women? 

Estradiol, the primary estrogen before menopause, ranges from 30 to 400 pg/mL depending on where a woman is in her menstrual cycle. Day 3 baseline values typically fall between 25 and 75 pg/mL. After menopause, estradiol levels drop to 0-30 pg/mL. Cycle timing matters: a single draw without knowing the cycle day is hard to interpret.

Can hormone levels be normal and still cause symptoms? 

Yes. Reference ranges cover a wide span of the population, and a result inside that range doesn't guarantee the absence of hormone-related symptoms. Symptoms like fatigue, reduced libido, and disrupted sleep are non-specific and can have many causes. Clinical evaluation pairs the lab value with the patient's full history to determine whether a hormonal contribution is present.

What hormones should be tested together? 

Hormone levels are often interpreted alongside related markers when a clinical question requires broader evaluation. A testosterone panel that doesn't include SHBG, estradiol, FSH, LH, and hematocrit may miss relevant patterns. For women, combining estradiol, progesterone, FSH, TSH, and free T3 can provide more clinical information than any single marker alone. The specific panel depends on the patient's symptoms, age, and reproductive status.

Why does the time of day matter for hormone testing? 

Testosterone levels peak in the early morning and decline through the afternoon. Clinical guidelines specify draws between 8:00 and 10:00 AM, fasting, to capture the most accurate reading. Drawing blood outside this window can produce results that underrepresent actual hormone production.

Do normal hormone levels change with age? 

Yes. Longitudinal data suggest testosterone in men declines at roughly 1-2% per year after age 40, though the pace varies by individual and is influenced by body composition and overall health. In women, estrogen and progesterone fluctuate across the menstrual cycle, shift during perimenopause, and decline after menopause. FSH rises as ovarian reserve decreases. Age-adjusted interpretation is part of reading any hormone result.

References

• J Clin Endocrinol Metab. 2017;102(4):1161-1173

• J Clin Endocrinol Metab. 2018;103(5):1715-1744

• J Urol. 2018;200(2):423-432

• FDA Drug Safety Communication. February 28, 2025